VASCADE Vascular Closure System was
approved by the FDA in 2013 and
approved for CE Marking in Europe 2012.
Clinical data from a prospective, multi-center, randomized 420 patient trial
demonstrated that VASCADE is clinically and statistically superior in both
safety and efficacy compared to manual compression, the gold standard for
vascular closure for patients undergoing percutaneous procedures through the